Group 1 - Su Bote's latest rolling P/E ratio is 55.52 and P/B ratio is 1.28, significantly higher than the industry averages of 19.61 and 0.81 respectively [3] - Agricultural Bank completed the issuance of 600 billion yuan in secondary capital bonds, with two types: 400 billion yuan fixed-rate bonds at 1.92% for 10 years and 200 billion yuan fixed-rate bonds at 2.12% for 15 years [4] - Nanjing Xinbai's major assets are frozen due to liquidity debt crisis faced by its controlling shareholder, but the company's operations remain normal [5] - Time Space Technology's stock is suspended as the controlling shareholder is planning a change in control [6] - Pioneer New Materials and its former controlling shareholder are under investigation by the CSRC for information disclosure violations, but it will not adversely affect the company's operations [7] - *ST Wan Fang's major shareholder's stock auction was canceled, indicating ongoing risks of control change [8] Group 2 - Zhimingda reported a net profit of 38.298 million yuan for the first half of 2025, a year-on-year increase of 2147.93% [10] - Leshan Electric's net profit for the first half of 2025 was 7.9031 million yuan, a decrease of 14.55% year-on-year, attributed to new pricing policies and increased costs [12] - Sainuo Medical expects a net profit of 13.84 million yuan for the first half of 2025, a year-on-year increase of 296.54%, driven by increased sales of coronary stents and balloons [13] Group 3 - Zhongqi New Materials' subsidiary signed a mining rights transfer contract, increasing the mining production capacity from 20 million tons/year to 40 million tons/year [15] - Zhonghuan Environmental Protection's major shareholder did not execute its planned share reduction of up to 15.0583 million shares by the deadline [17] - Zhangyue Technology plans to reduce its holdings by up to 438,900 shares, not exceeding 1% of the total share capital [18]

Group 1 - Leshan Electric achieved operating revenue of 1.623 billion yuan, a year-on-year increase of 1.94%, and a net profit of 7.9031 million yuan, a year-on-year decrease of 14.55% [1] - Zhimingda reported operating revenue of 295 million yuan, a year-on-year increase of 84.83%, and a net profit of 38.3 million yuan, a year-on-year increase of 2147.93% [2] - Dahu Co. reported operating revenue of 426 million yuan, a year-on-year decrease of 14.40%, and a net loss of 2.5716 million yuan, an improvement from a loss of 13.7824 million yuan in the same period last year [3] - Yubang Electric expects a net profit of 21.2 million to 25 million yuan, a year-on-year decrease of 35.47% to 45.28% [4] - Zhejiang Securities achieved operating revenue of 6.512 billion yuan, a year-on-year decrease of 18.60%, and a net profit of 1.149 billion yuan, a year-on-year increase of 46.54% [5] - Huashu Media reported operating revenue of 4.435 billion yuan, a year-on-year increase of 2.07%, and a net profit of 254 million yuan, a year-on-year increase of 4.63% [7] Group 2 - Sinopec reported oil and gas equivalent production of 262.81 million barrels, a year-on-year increase of 2%, and crude oil processing volume of 119.97 million tons, a year-on-year decrease of 5.3% [8] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS8179, aimed at reducing brain edema after stroke [8] - Hengrui Medicine's subsidiary also received approval for clinical trials of HRS-1893, intended for treating heart failure with preserved ejection fraction [8] - Wanfu Co. announced a plan to reduce its stake by up to 2% through block trading [10] - Biological Co. received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inaccuracies in financial reporting [11] - Zhujiang Co. reported a signed construction area of 47.1432 million square meters across 396 projects [13] Group 3 - Watson Bio received a patent for a peptide delivery system for RNA drugs [15] - Sanwei Chemical signed 31 new contracts worth 335 million yuan in the second quarter [17] - Shenzhou Cell's SCT640C injection received approval for clinical trials for rheumatoid arthritis [18] - Xinjiang Jiaojian reported new contracts worth 1.434 billion yuan in the second quarter [19] - Lais Information plans to use 550 million yuan of idle funds for cash management [21] - Zhongqi New Materials signed a mining rights transfer contract, increasing production capacity [22] Group 4 - Hengtong Optic-Electric won multiple marine energy projects worth 1.509 billion yuan [24] - China State Construction signed new contracts totaling 2.501 trillion yuan in the first half of the year [26] - David Medical's ventilator product registration application has been accepted [28] - Tianhai Defense's subsidiary signed a construction contract worth 16.224 million yuan [29] - Nantian Information plans to sign a procurement framework contract worth 58.27 million yuan with its controlling shareholder [31] - Baida Group announced a plan to reduce its stake by up to 3% [32] Group 5 - Jinli Permanent Magnet plans to issue $117.5 million in convertible bonds [34] - Haizheng Pharmaceutical's fumarate bedaquiline raw material drug application has been approved [36] - Huatai passed the advanced intelligent factory re-evaluation in Anhui Province [37] - Everbright Bank's shareholder increased its stake from 7.08% to 8% [40] - Supor reported total operating revenue of 11.478 billion yuan, a year-on-year increase of 4.68%, and a net profit of 940 million yuan, a year-on-year decrease of 0.07% [41] - Qianjin Pharmaceutical's subsidiaries received registration certificates for two drugs [42]

成都智明达电子股份有限公司 2025 年上半年，归属于母公司所有者的净利润 3,829.80 万元，较上年同期 上升 2,147.93%；归属于母公司所有者的扣除非经常性损益的净利润 3,568.25 万元，较上年同期实现扭亏为盈，增加 3,695.61 万元。 为推动提升成都智明达电子股份有限公司（以下简称"公司"）投资价值， 增强投资者回报，同时秉持"投资者为市场之本，上市公司为市场之基"的理念， 在合规、科学、有效的原则下，切实维护股东权益，树立公司良好的资本市场形 象，公司于 2025 年 4 月 25 日发布了 2025 年度"提质增效重回报"行动方案（以 下简称"行动方案"），切实履行上市公司的责任和义务，共同促进资本市场平 稳健康发展。2025 年上半年，公司根据行动方案内容，积极开展和落实各项工 作，现将 2025 年上半年主要进展及成效情况报告如下： 一、聚焦主营业务，提升经营质量，夯实核心竞争力 2025 年上半年，公司实现营业总收入 29,475.64 万元，较上年同期上升 84.83%。截止报告期末，在手订单 6.08 亿元（含口头订单），较上年同期增加 73.71%。 2025 年提 ...

成都智明达电子股份有限公司 2025 年半年度报告 公司代码：688636 公司简称：智明达 成都智明达电子股份有限公司 2025 年半年度报告 1 / 149 成都智明达电子股份有限公司 2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险。公司已在报告中详细描 述可能存在的相关风险，敬请查阅本报告"第三节 管理层讨论与分析" 之 "四、风险因素"。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人龙波、主管会计工作负责人刘馨竹及会计机构负责人（会计主管人员）李婷声 明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性描述，不构成公司对投资者的实质性承诺， ...

证券代码：688636 证券简称：智明达 公告编号：2025-043 成都智明达电子股份有限公司 第三届董事会第二十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 成都智明达电子股份有限公司（以下简称"公司"）第三届董事会第二十七 次会议于 2025 年 7 月 24 日在公司会议室以现场结合通讯方式召开。会议通知已 于 2025 年 7 月 14 日以邮件方式送达全体董事。本次会议应出席董事 7 名，实际 出席董事 7 名。本次会议由董事长王勇先生召集并主持。本次会议的召集和召开 程序符合有关法律、行政法规、部门规章、规范性文件和《公司章程》的规定， 会议决议合法、有效。 二、董事会会议审议情况 经与会董事审议，逐项表决，形成如下决议： （一） 审议通过《关于公司 2025 年半年度报告及其摘要的议案》 公司根据《公开发行证券的公司信息披露内容与格式准则第 3 号——半年度 报告的内容与格式（2025 年修订）》《上海证券交易所股票上市规则（2025 年 4 月修订）》《上海证券交易 ...

Group 1 - The company reported a revenue of 295 million yuan for the first half of 2025, representing a year-on-year growth of 84.83% [1] - The net profit for the same period reached 38.298 million yuan, showing a significant year-on-year increase of 2147.93% [1]

成都智明达电子股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 07 月 28 日 （星期一） 15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 07 月 21 日 （星期一） 至 07 月 25 日 （星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 688636zmd@zmdde.com 进行提问。公司将在说明会上对投资者普遍关注的问题 进行回答。 证券代码：688636 证券简称：智明达 公告编号：2025-042 成都智明达电子股份有限公司（以下简称"公司"）将于 2025 年 7 月 25 日发 布公司 2025 年半年度报告，为便于广大投资者更全面深入地了解公司 2025 年半 年度经营成果 ...

Core Viewpoint - The legal opinion letter confirms the legality of the convening and conducting of the 2025 second extraordinary general meeting of Chengdu Zhimianda Electronics Co., Ltd, ensuring compliance with relevant laws and regulations [1][2][7] Group 1: Meeting Procedures - The meeting was convened by the company's board of directors based on a resolution from the 26th meeting of the third board [2] - The meeting utilized a combination of on-site and online voting, with specific timeframes for network voting provided [2][3] - The actual time, location, and method of the meeting were consistent with the notification sent to shareholders [2][3] Group 2: Attendance and Qualifications - Eligible attendees included registered shareholders and their authorized representatives, with a total of 56 participants representing 8,127,461 shares (approximately 4.85% of total voting shares) in attendance [3] - Online voting saw participation from 52 shareholders, representing 20,504,488 shares (approximately 12.23% of total voting shares) [3][4] - The qualifications of attendees and the convenor were verified as legitimate [4] Group 3: Voting Procedures and Results - Voting was conducted through a combination of on-site and online methods, with results monitored and announced in accordance with company bylaws [5] - The first resolution received 28,541,858 votes in favor (99.69%), with 90,091 against (0.31%), and was passed [5][6] - The second resolution garnered 28,592,729 votes in favor (99.86%), with 39,220 against (0.14%), and was also passed [5][6] - The third resolution achieved 28,592,868 votes in favor (99.86%), with 39,081 against (0.14%), confirming its passage [6][7] Group 4: Conclusion - The legal opinion concludes that the meeting's procedures, participant qualifications, and voting results are all in compliance with applicable laws and regulations [7]

Meeting Details - The shareholders' meeting of Chengdu Zhimingda Electronics Co., Ltd. was held on July 16, 2025, at the conference room located at No. 108, Jingye Road, Chengdu [1] - A total of 56 ordinary shareholders attended the meeting, holding 28,631,949 voting rights, which accounts for 17.0716% of the company's total voting rights [1] Voting Results - The proposal regarding the dilution of immediate returns and measures to mitigate risks was approved with 28,541,858 votes in favor (99.6853%), 90,091 votes against (0.3147%), and no abstentions [1] - The proposal concerning the three-year dividend return plan (2025-2027) was also approved with 28,592,729 votes in favor (99.8630%), 39,220 votes against (0.1370%), and no abstentions [1] - Another proposal was approved with 28,592,868 votes in favor (99.8635%), 39,081 votes against (0.1365%), and no abstentions [1] Legal Compliance - The meeting was convened and conducted in accordance with the Company Law, Securities Law, and the company's articles of association, ensuring the legality of the participants and the voting process [2]

证券代码：688636 证券简称：智明达 公告编号：2025-041 成都智明达电子股份有限公司 2025 年第二次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 07 月 16 日 （二） 股东会召开的地点：成都市敬业路 108 号 T 区 1 栋 12 楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 56 | | --- | --- | | 普通股股东人数 | 56 | | 2、出席会议的股东所持有的表决权数量 | 28,631,949 | | 普通股股东所持有表决权数量 | 28,631,949 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 17.0716 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 17.0716 | （四 ...